Sign in

CIK 0001620463

  • Non-accelerated filer
  • Smaller reporting company

LeonaBio, Inc.

Sign in to watch
Ticker
LONA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
453368487
Phone
+1 425-620-8501
Business address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Former names
Athira Pharma, Inc., M3 Biotechnology, Inc.
Open-market buys, last 90 days
$9,919,161,281
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Portman David J. +$9.9B 10% owner 1 filing
Date Insider Transaction Shares Price Value Owned after
2021-06-10 MILESON GLENNA Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −6,305 6,305
2021-06-08 CHURCH KEVIN Vice President of Discovery Exercise or conversion +3,152 $1.04 $3K 44,318
2021-06-08 CHURCH KEVIN Vice President of Discovery Exercise or conversion · Stock Option (Right to Buy) −3,152 0
2021-06-08 CHURCH KEVIN Vice President of Discovery Exercise or conversion +3,152 $1.04 $3K 44,133
2021-06-08 CHURCH KEVIN Vice President of Discovery Exercise or conversion · Stock Option (Right to Buy) −3,152 0
2021-05-28 FLUKE JOHN M JR Director Grant or award · Stock Option (Right to Buy) +13,871 13,871
2021-05-28 Yamada Tadataka Director Grant or award · Stock Option (Right to Buy) +13,871 13,871
2021-05-28 JOHNSON JAMES A Director Grant or award · Stock Option (Right to Buy) +13,871 13,871
2021-05-28 EDELMAN JOSEPH Director Grant or award · Stock Option (Right to Buy) +13,871 13,871
2021-05-28 PERCEPTIVE ADVISORS LLC Director Grant or award · Stock Option (Right to Buy) +13,871 13,871
2021-05-18 Litton Mark James Chief Operating Officer Grant or award +867 $14.45 $13K 64,433
2021-05-18 MOEBIUS HANS Chief Medical Officer Grant or award +2,055 $14.45 $30K 2,055
2021-05-18 MILESON GLENNA Chief Financial Officer Grant or award +1,554 $14.45 $22K 83,519
2021-05-18 CHURCH KEVIN Vice President of Discovery Grant or award +185 $14.45 $3K 41,166
2021-03-04 Kosacz Barbara Director Grant or award · Stock Option (Right to Buy) +27,742 27,742
2021-02-18 MOEBIUS HANS Chief Medical Officer Grant or award · Stock Option (Right to Buy) +72,000 72,000
2021-02-18 MILESON GLENNA Chief Financial Officer Grant or award · Stock Option (Right to Buy) +73,500 73,500
2021-02-18 Litton Mark James Chief Operating Officer Grant or award · Stock Option (Right to Buy) +85,000 85,000
2021-02-18 KAWAS LEEN President & CEO Grant or award · Stock Option (Right to Buy) +231,000 231,000
2021-02-18 CHURCH KEVIN Vice President of Discovery Grant or award · Stock Option (Right to Buy) +20,000 20,000

Page 16 of 18 · 349 trades